Subham Preetam (He/Him)

Early Stage Researcher (R1), DGIST

About Subham Preetam

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals.

With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. His research aims to improve the life expectancy of sea animals and humans.

Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, US, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.

Research Interest

Apoptosis Biotechnology Cancer Drug Design Neuroscience Stem Cells

FEBS Constituent Society

UK (Biochemical Society)

Other Expertise/Interests

Journal publishing Scientific administration Scientific communication Undergraduate teaching

Followed by


Online Elsewhere